A Benefit/Risk Analysis of the Prevention of Brain Ischaemia with Anticoagulant Drugs: When, How and Whom to Treat?

Publisher： Karger

E-ISSN： 1421-9786|11|1|100-104

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.11, Iss.1, 2010-04, pp. : 100-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme

By Beckett J R   Kotre C J   Michaelson J S  

British Journal of Radiology, Vol. 76, Iss. 905, 2003-05 ,pp. : 309-320

British Institute of Radiology

Access to resources Recommend Favorite

Hormonal Replacement in Patients with Brain Injury-Induced Hypopituitarism: Who, When and How to Treat?

By Estes Susie   Urban Randall  

Pituitary, Vol. 8, Iss. 3-4, 2005-12 ,pp. : 267-270

Springer Publishing Company

Access to resources Recommend Favorite

High Blood Pressure as Risk Factor and Prognostic Predictor in Acute Ischaemic Stroke: When and How to Treat It?

By  

Cerebrovascular Diseases, Vol. 17, Iss. 1, 2003-12 ,pp. : 51-57

Karger

Access to resources Recommend Favorite

When and how to treat acute hepatitis C?

By Licata A.   Di Bona D.   Schepis F.   Shahied L.   Craxi A.   Camma C.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1056-1062

Elsevier

Access to resources Recommend Favorite

Risk and Benefit of Statins in Stroke Secondary Prevention

By  

Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. : 812-816

Bentham Science Publishers

Access to resources Recommend Favorite